---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-24-000209"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:36:40.921905+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Globus Medical receives FDA warning letter for ExcelsiusGPS complaint procedures

## Summary
- FDA warning letter cites non-conformities in complaint handling, trending, risk reconciliation, and MDR reporting for the ExcelsiusGPS robotic system.
- Inspection occurred Feb 15–Mar 7, 2024; company says deficiencies in response letters to the Form 483.
- No safety concerns with use of the system or manufacturing process were identified.
- Company has taken corrective actions and believes issues can be resolved without material financial impact.
- Until resolution, additional regulatory action may be taken without further notice.

## SEC filing metadata
- accession: 0001562762-24-000209
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000209/0001562762-24-000209-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000209/gmed-20240716x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-24-000209
- JSON: https://secwatch.observer/filing/0001562762-24-000209.json
- Plain text: https://secwatch.observer/filing/0001562762-24-000209.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.